PS
PRCT icon

Principal Securities’s Procept Biorobotics PRCT Stock Holding History

Principal Securities’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-34
Closed -$1.21K – 2948
2025
Q3 		$1.21K Buy
34
+6
+21% +$274 ﹤0.01% 3358
2025
Q2 		$1.61K Sell
28
-96
-77% -$5.43K ﹤0.01% 3208
2025
Q1 		$9.98K Hold
124
– – ﹤0.01% 2524
2024
Q4 		$9.98K Buy
124
+24
+24% +$2.05K ﹤0.01% 2520
2024
Q3 		$8.01K Buy
+100
New +$7.1K ﹤0.01% 2529

Other funds holding PRCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Principal Securities's PRCT Position: Q4 2025 in Review

Principal Securities sold out of Procept Biorobotics (PRCT) in Q4 2025, closing a stake of 34 shares — an estimated $1.21K sold.

Principal Securities first reported a position in PRCT in Q3 2024 and held it in 5 quarters. The position peaked at $9.98K in Q1 2025. 263 funds tracked by Wall St. Rank hold PRCT as of Q4 2025.

  • Principal Securities reported no remaining Procept Biorobotics position as of Q4 2025 after selling out during the quarter.
  • Principal Securities sold 34 Procept Biorobotics shares in Q4 2025, an estimated $1.21K.
  • Principal Securities first reported a position in Procept Biorobotics in Q3 2024 and held it in 5 quarters.
  • Principal Securities's Procept Biorobotics position peaked at $9.98K in Q1 2025.
  • 263 funds tracked by Wall St. Rank held Procept Biorobotics as of Q4 2025.

Based on Principal Securities's 13F filing for Q4 2025, filed 12 Feb 2026.